In Vitro Toxicity Testing Market by Product (Assay (Western Blot, Tissue Culture),Equipment, Assay Reagent, Software), Toxicity Endpoints (ADME, Skin Irritation, Corrosion),Industry (Pharmaceutical, Cosmetics)-COVID-19 Impact - Global Forecast to 2025

体外毒性検査の世界市場予測(〜2025):製品別(アッセイ(ウエスタンブロット、組織培養)、機器、アッセイ試薬、ソフトウェア)、毒性エンドポイント別(ADME、皮膚刺激性、腐食)、産業別(医薬品、化粧品)、新型コロナウイルスの影響

◆タイトル:In Vitro Toxicity Testing Market by Product (Assay (Western Blot, Tissue Culture),Equipment, Assay Reagent, Software), Toxicity Endpoints (ADME, Skin Irritation, Corrosion),Industry (Pharmaceutical, Cosmetics)-COVID-19 Impact - Global Forecast to 2025
◆商品コード:BT 2373
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年8月31日
◆ページ数:341
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

Marketsandmarkets社は体外毒性検査の世界市場が2020年91億ドルから2025年149億ドルまで、年平均10.3%成長すると予測しています。本調査レポートでは、体外毒性検査の世界市場を調査・分析することで、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、産業見通し、製品・サービス別(消耗品、アッセイ、装置、ソフトウェア)分析、毒性エンドポイント・検査別(ADME(吸収、分布、代謝、排泄)検査、皮膚刺激、腐食・感作性検査、遺伝毒性検査、細胞毒性検査)分析、技術別(細胞培養技術、ハイスループット技術、トキシコゲノミクス (毒性ゲノム学))分析、産業別(医薬品・バイオ医薬品、化粧品・家庭用品、食品、化学薬品)分析、方式別(細胞アッセイ、生化学的アッセイ、IN SILICOモデル、EX-VIVOモデル)分析、地域別分析、競争状況、企業概要、関連市場など、今後の市場展望をまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・産業見通し
・体外毒性検査の世界市場規模:製品・サービス別(消耗品、アッセイ、装置、ソフトウェア)
・体外毒性検査の世界市場規模:毒性エンドポイント・検査別(ADME(吸収、分布、代謝、排泄)検査、皮膚刺激、腐食・感作性検査、遺伝毒性検査、細胞毒性検査)
・体外毒性検査の世界市場規模:技術別(細胞培養技術、ハイスループット技術、トキシコゲノミクス (毒性ゲノム学))
・体外毒性検査の世界市場規模:産業別(医薬品・バイオ医薬品、化粧品・家庭用品、食品、化学薬品)
・体外毒性検査の世界市場規模:方式別(細胞アッセイ、生化学的アッセイ、IN SILICOモデル、EX-VIVOモデル)
・体外毒性検査の世界市場規模:地域別
・競争状況
・企業概要
・関連市場

“The global in vitro toxicology testing market is projected to grow at a CAGR of 10.3%.”
The in vitro toxicology testing market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%. The opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the primary growth factors for this market. The increasing focus of the pharmaceutical and cosmetics industries on using in vitro methods for product testing along with the improving in silico methods for predictive toxicology studies are expected to offer significant growth opportunities for players in this market. However, the dearth of skilled professionals is a major market challenge.

“The software segment is expected to grow at the highest rate during the forecast period.”
Based on the product and service, the in vitro toxicology testing market is segmented into consumables, assays, equipment, software, and services. The software segment is projected to witness the highest growth in the in vitro toxicology testing market during the forecast period. Growth in this segment is driven mostly by the growing number of new technologies to develop in vitro signatures and computational models capable of predicting in vivo responses. Also, the increasing use of these softwares in industry and the academia to predict toxicity by comparing the data of new substances with other structurally or biologically similar compounds whose effects are also expected to drive the growth of this segment.

“The ADME segment is expected to account for the largest market share in 2019.”
Based on toxicity endpoints and tests undertaken across all industries, the in vitro toxicity testing market is segmented into ADME; skin irritation, corrosion, and sensitization; genotoxicity; cytotoxicity; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endpoints & tests. The ADME segment accounted for the largest share of the in vitro toxicity testing market in 2018. This can be attributed to the high adoption during the drug development process with the advantage of producing highly reproducible & accurate data.

“Toxicogenomics is expected to grow at the highest rate during the forecast period.”
The toxicogenomics segment is expected to grow at the highest CAGR during the forecast period, primarily due to the technological advancements taking place in the field of proteomics and genomics.

“Europe is expected to hold the largest share for players operating in the in vitro toxicology testing market.”
Europe accounted for the largest share of the in vitro toxicology testing market in 2019. Factors such as high adoption of in vitro toxicology testing assays and services in the cosmetics and chemical industries after the ban on animal testing in the region are among the few factors expected to contribute to the growth of this market.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level (35%), Director-level (25%), and Others (40%)
• By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and the Middle East & Africa (2%)

Key players in the In Vito Toxiocology Testing Market
The prominent players in the in vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), MB Research Laboratories (US) ,Creative Biolabs(US), GVK Biosciences Private Limited (India), Shanghai Medicon Inc (China), Creative Biorray (US) and Insphero (Switzerland).

Research Coverage:
This report analyzes the market for various in vitro toxicology testing products and their adoption patterns. It aims at estimating the market size and future growth potential of the global in vitro toxicology testing market and its product & service, technology, toxicity endpoint & test, industry, method, and regional segments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global in vitro toxicology testing market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global in vitro toxicology testing market
• Market Development: Comprehensive information on the lucrative emerging regions
• Market Diversification: Exhaustive information about the new product, growing geographies, and recent developments in the global in vitro toxicology testing market
• Competitive Assessment: In-depth assessment of market ranking, growth strategies, revenue analysis, and services of leading players in the global in vitro toxicology testing market

【レポートの目次】

1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.2.1 INCLUSIONS AND EXCLUSIONS 42
1.2.2 MARKETS COVERED 43
FIGURE 1 IN VITRO TOXICOLOGY TESTING MARKET 43
1.2.3 YEARS CONSIDERED FOR THE STUDY 44
1.3 CURRENCY 44
1.4 STAKEHOLDERS 44
1.5 LIMITATIONS 45
1.6 SUMMARY OF CHANGES 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH APPROACH 46
FIGURE 2 RESEARCH DESIGN 46
2.1.1 SECONDARY RESEARCH 46
2.1.1.1 Key data from secondary sources 47
2.1.2 PRIMARY RESEARCH 48
2.1.2.1 Key data from primary sources 48
2.1.2.2 Breakdown of primaries 49
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 49
2.2 MARKET SIZE ESTIMATION & VALIDATION APPROACH 49
FIGURE 4 MARKET SIZE APPROACH 51
FIGURE 5 BOTTOM-UP APPROACH 51
2.3 DATA TRIANGULATION APPROACH 52
FIGURE 6 DATA TRIANGULATION METHODOLOGY 52
2.4 MARKET SHARE ESTIMATION 53
2.5 ASSUMPTIONS FOR THE STUDY 53
3 EXECUTIVE SUMMARY 54
FIGURE 7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2020 VS. 2025 (USD MILLION) 54
FIGURE 8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020 VS. 2025 (USD MILLION) 55
FIGURE 9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION) 56
FIGURE 10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020 VS. 2025 (USD MILLION) 56
FIGURE 11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020 VS. 2025 (USD MILLION) 57
FIGURE 12 GEOGRAPHIC ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET 58
4 PREMIUM INSIGHTS 59
4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW 59
FIGURE 13 OPPOSITION TO ANIMAL TESTING IS A MAJOR FACTOR DRIVING MARKET GROWTH 59
4.2 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD 60
FIGURE 14 CELLULAR ASSAYS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC IN VITRO TOXICOLOGY TESTING MARKET IN 2019 60
4.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
FIGURE 15 CHINA SHOWS THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD 61
4.4 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION (2018–2025) 62
FIGURE 16 EUROPE WILL CONTINUE TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET IN 2025 62
4.5 IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS 63
FIGURE 17 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
FIGURE 18 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
5.2.1 MARKET DRIVERS 65
5.2.1.1 Opposition to animal testing 65
5.2.1.2 Technological advancements 66
5.2.1.3 R&D on early-stage toxicity detection 66
5.2.2 MARKET RESTRAINTS 67
5.2.2.1 Reluctance of regulatory authorities to consider alternative methods for proving safety and efficacy 67
5.2.2.2 Failure to establish the intricacies of in vivo conditions 67
5.2.2.3 Lack of in vitro models to study complex endpoints 68
5.2.3 MARKET OPPORTUNITIES 68
5.2.3.1 Increasing focus on drug discovery and personalized medicine using in vitro methods 68
5.2.3.2 Increasing number of toxicology databases 69
5.2.4 MARKET CHALLENGES 70
5.2.4.1 Dearth of skilled professionals 70
6 INDUSTRY INSIGHTS 71
6.1 INTRODUCTION 71
6.2 INDUSTRY TRENDS 71
6.2.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY 71

6.3 SUPPLY CHAIN ANALYSIS 72
FIGURE 19 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET 72
6.4 REGULATORY COMMITTEE ACTIVITIES 72
6.4.1 MAJOR STAKEHOLDERS 73
6.4.2 KEY INFLUENCERS 73
6.5 COVID-19 IMPACT ON THE IN VITRO TOXICOLOGY MARKET 74
FIGURE 20 IMPACT OF COVID-19 ON IN VITRO TOXICOLOGY TESTING MARKET 75
7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE 76
7.1 INTRODUCTION 77
7.2 COVID-19 IMPACT, BY PRODUCT & SERVICE 77
FIGURE 21 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD 77
TABLE 1 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2017–2019 (USD MILLION) 78
TABLE 2 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2020–2025 (USD MILLION) 78
7.3 CONSUMABLES 79
7.3.1 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD 79
TABLE 3 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 80
TABLE 4 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 80
7.4 ASSAYS 81
TABLE 5 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2019 (USD MILLION) 81
TABLE 6 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020–2025 (USD MILLION) 82
TABLE 7 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 82
TABLE 8 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 83
7.4.1 BACTERIAL TOXICITY ASSAYS 83
7.4.1.1 Bacterial assays dominate the market as they are the most widely adopted assay type across industries 83
TABLE 9 BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 84
TABLE 10 BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 84
7.4.2 ENZYME TOXICITY ASSAYS 85
7.4.2.1 Enzyme toxicity assays are increasingly used for endocrine-disrupting studies—a key factor driving market growth 85
TABLE 11 ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 85
TABLE 12 ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 86
7.4.3 CELL-BASED ELISA & WESTERN BLOTS 86
7.4.3.1 Cell-based assays are cost-effective, owing to which they are witnessing increasing adoption in drug discovery 86
TABLE 13 CELL-BASED ELISA & WESTERN BLOTS MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 87
TABLE 14 CELL-BASED ELISA & WESTERN BLOTS MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 88
7.4.4 RECEPTOR-BINDING ASSAYS 88
7.4.4.1 Receptor-binding assays are well-suited for high-throughput formats, a key factor driving the adoption of these products 88
TABLE 15 RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 89
TABLE 16 RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 89
7.4.5 TISSUE CULTURE ASSAYS 90
7.4.5.1 Tissue culture assays offer the advantage of mimicking in vivo tissue architecture 90
TABLE 17 TISSUE CULTURE ASSAYS MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 90
TABLE 18 TISSUE CULTURE ASSAYS MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 91
7.4.6 OTHER ASSAYS 91
TABLE 19 OTHER ASSAYS MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 92
TABLE 20 OTHER ASSAYS MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 92
7.5 EQUIPMENT 93
7.5.1 FULLY AUTOMATED EQUIPMENT IS WITNESSING GROWING ADOPTION IN RESEARCH 93
TABLE 21 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 94
TABLE 22 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 94
7.6 SOFTWARE 95
7.6.1 SOFTWARE TOOLS ARE VITAL IN REDUCING ANALYSIS TIMES AND MANAGING LARGE AMOUNTS OF DATA GENERATED IN OPERATIONS 95
TABLE 23 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 95
TABLE 24 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 96
7.7 SERVICES 96
7.7.1 LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS 96
TABLE 25 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 97
TABLE 26 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 98

8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST 99
8.1 INTRODUCTION 100
FIGURE 22 ORGAN TOXICITY TESTING TO REGISTER THE HIGHEST GROWTH IN THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD 100
TABLE 27 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 101
TABLE 28 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 101
8.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING 102
8.2.1 ADME TESTING TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD 102
TABLE 29 ADME TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 103
TABLE 30 ADME TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 103
8.3 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING 104
8.3.1 SKIN IRRITATION, CORROSION, AND SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN THE COSMETICS INDUSTRY 104
TABLE 31 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET,
BY COUNTRY, 2017–2019 (USD MILLION) 105
TABLE 32 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET,
BY COUNTRY, 2020–2025 (USD MILLION) 105
8.4 GENOTOXICITY TESTING 106
8.4.1 MORE GENOTOXICITY TESTS ARE REVIEWED AND VALIDATED BY REGULATORY AUTHORITIES THAN ANY OTHER ENDPOINT— A KEY DRIVER FOR MARKET GROWTH 106
TABLE 33 GENOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 107
TABLE 34 GENOTOXICITY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 107
8.5 CYTOTOXICITY TESTING 108
8.5.1 RISING NEED FOR BIOSAFETY IS LARGELY CONTRIBUTING TO THE GROWTH OF THE CYTOTOXICITY TESTING MARKET 108
TABLE 35 CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 109
TABLE 36 CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 109
8.6 OCULAR TOXICITY TESTING 110
8.6.1 IN VITRO AND EX VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING 110
TABLE 37 OCULAR TOXICITY TESTING MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 110
TABLE 38 OCULAR TOXICITY TESTING MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 111
8.7 ORGAN TOXICITY TESTING 111
8.7.1 HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY 111
TABLE 39 ORGAN TOXICITY TESTING MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 112
TABLE 40 ORGAN TOXICITY TESTING MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 112

8.8 PHOTOTOXICITY TESTING 113
8.8.1 VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE THE PHOTOSAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS 113
TABLE 41 PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 113
TABLE 42 PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 114
8.9 DERMAL TOXICITY TESTING 114
8.9.1 IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN THE COMING YEARS 114
TABLE 43 DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 115
TABLE 44 DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 115
8.10 OTHER TOXICITY ENDPOINTS & TESTS 116
TABLE 45 OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 116
TABLE 46 OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 117
9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY 118
9.1 INTRODUCTION 119
FIGURE 23 TOXICOGENOMICS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 119
TABLE 47 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2019 (USD MILLION) 119
TABLE 48 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 120
9.2 CELL CULTURE TECHNOLOGIES 120
9.2.1 CELL- & TISSUE-BASED TECHNOLOGIES ARE THE MOST WIDELY ADOPTED IN IN VITRO TESTING 120
TABLE 49 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES, BY COUNTRY, 2017–2019 (USD MILLION) 121
TABLE 50 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES, BY COUNTRY, 2020–2025 (USD MILLION) 122
9.3 HIGH-THROUGHPUT TECHNOLOGIES 122
9.3.1 INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IS DRIVING MARKET GROWTH 122
TABLE 51 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY, 2017–2019 (USD MILLION) 123
TABLE 52 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY, 2020–2025 (USD MILLION) 124
9.4 TOXICOGENOMICS 124
9.4.1 IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ARE ENHANCING THE STUDY OF GENE & PROTEIN ACTIVITY DURING TOXICITY ANALYSIS 124
TABLE 53 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS,
BY COUNTRY, 2017–2019 (USD MILLION) 125
TABLE 54 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS,
BY COUNTRY, 2020–2025 (USD MILLION) 126
10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY 127
10.1 INTRODUCTION 128
FIGURE 24 PHARMACEUTICALS & BIOPHARMACEUTICALS TO COMMAND THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD 128
TABLE 55 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2019 (USD MILLION) 128
TABLE 56 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 129
10.2 COVID-19 IMPACT, BY INDUSTRY 129
10.3 PHARMACEUTICALS & BIOPHARMACEUTICALS 129
10.3.1 DRUG ATTRITION RATE IS LEADING TO THE HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN THE EARLY STAGES OF DRUG DEVELOPMENT 129
TABLE 57 PHARMACEUTICAL & BIOPHARMACEUTICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 131
TABLE 58 PHARMACEUTICAL & BIOPHARMACEUTICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 131
10.4 COSMETICS & HOUSEHOLD PRODUCTS 132
10.4.1 BAN ON ANIMAL TESTING IS INCREASING THE ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING 132
TABLE 59 COSMETIC & HOUSEHOLD PRODUCT IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 133
TABLE 60 COSMETIC & HOUSEHOLD PRODUCT IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 133
10.5 FOOD 134
10.5.1 INCREASING FOCUS ON FOOD SAFETY IS DRIVING MARKET GROWTH 134
TABLE 61 TYPES OF TOXICOLOGICAL TESTS IN THE FOOD INDUSTRY 134
TABLE 62 FOOD IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 135
TABLE 63 FOOD IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 136
10.6 CHEMICALS 136
10.6.1 INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICAL TESTING IS PROPELLING THE MARKET 136
TABLE 64 CHEMICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 137
TABLE 65 CHEMICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 138
11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD 139
11.1 INTRODUCTION 140
FIGURE 25 IN SILICO MODELS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 140
TABLE 66 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2019 (USD MILLION) 140
TABLE 67 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 141

11.2 CELLULAR ASSAYS 141
11.2.1 DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS 141
TABLE 68 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS,
BY COUNTRY, 2017–2019 (USD MILLION) 142
TABLE 69 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS,
BY COUNTRY, 2020–2025 (USD MILLION) 143
11.3 BIOCHEMICAL ASSAYS 143
11.3.1 BIOCHEMICAL ASSAYS FIND WIDER APPLICATION IN THE PHARMACEUTICAL INDUSTRY AS COMPARED TO THE CHEMICAL AND FOOD INDUSTRIES 143
TABLE 70 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS,
BY COUNTRY, 2017–2019 (USD MILLION) 144
TABLE 71 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS,
BY COUNTRY, 2020–2025 (USD MILLION) 145
11.4 IN SILICO MODELS 145
11.4.1 IN SILICO MODELS ARE EXPECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 145
TABLE 72 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS,
BY COUNTRY, 2017–2019 (USD MILLION) 146
TABLE 73 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS,
BY COUNTRY, 2020–2025 (USD MILLION) 147
11.5 EX-VIVO MODELS 147
11.5.1 EX-VIVO MODELS ARE WIDELY USED IN SKIN & EYE TOXICITY TESTING IN THE COSMETIC INDUSTRY 147
TABLE 74 IN VITRO TOXICOLOGY TESTING MARKET FOR EX-VIVO MODELS, BY COUNTRY, 2017–2019 (USD MILLION) 148
TABLE 75 IN VITRO TOXICOLOGY TESTING MARKET FOR EX-VIVO MODELS, BY COUNTRY, 2020–2025 (USD MILLION) 148
12 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION 149
12.1 INTRODUCTION 150
12.2 COVID-19 IMPACT, BY REGION 150
FIGURE 26 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT (2019) 151
TABLE 76 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION,
2017–2019 (USD MILLION) 152
TABLE 77 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION,
2020–2025 (USD MILLION) 152
12.3 EUROPE 152
FIGURE 27 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT 154
TABLE 78 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 155
TABLE 79 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 155
TABLE 80 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 156
TABLE 81 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 156
TABLE 82 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2019 (USD MILLION) 157
TABLE 83 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020–2025 (USD MILLION) 157
TABLE 84 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 158
TABLE 85 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 158
TABLE 86 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2019 (USD MILLION) 159
TABLE 87 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 159
TABLE 88 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2019 (USD MILLION) 159
TABLE 89 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 160
TABLE 90 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024
(USD MILLION) 160
TABLE 91 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 160
12.3.1 GERMANY 161
12.3.1.1 Germany holds the largest share of the European market 161
TABLE 92 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 162
TABLE 93 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 162
TABLE 94 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2019 (USD MILLION) 162
TABLE 95 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020–2025 (USD MILLION) 163
TABLE 96 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 163
TABLE 97 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 164
TABLE 98 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2019 (USD MILLION) 164
TABLE 99 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 165
TABLE 100 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2019 (USD MILLION) 165
TABLE 101 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 165
TABLE 102 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2019 (USD MILLION) 166
TABLE 103 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 166
12.3.2 UK 166
12.3.2.1 Rising awareness, growing R&D, and increasing collaborations are key indicators of market growth in the UK 166
TABLE 104 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 167
TABLE 105 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 168
TABLE 106 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2019 (USD MILLION) 168
TABLE 107 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020–2025 (USD MILLION) 169
TABLE 108 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 169
TABLE 109 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 170
TABLE 110 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2019 (USD MILLION) 170
TABLE 111 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 170
TABLE 112 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2019 (USD MILLION) 171
TABLE 113 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 171
TABLE 114 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2019 (USD MILLION) 171
TABLE 115 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 172
12.3.3 FRANCE 172
12.3.3.1 Research initiatives supported by the government are aiding market growth in France 172
TABLE 116 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 173
TABLE 117 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 173
TABLE 118 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2019 (USD MILLION) 174
TABLE 119 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020–2025 (USD MILLION) 174
TABLE 120 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 175
TABLE 121 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 175
TABLE 122 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2019 (USD MILLION) 176
TABLE 123 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 176
TABLE 124 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2019 (USD MILLION) 176
TABLE 125 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 177
TABLE 126 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2019 (USD MILLION) 177
TABLE 127 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 177
12.3.4 ITALY 178
12.3.4.1 Growth in this market is mainly driven by the increasing
life science R&D 178
TABLE 128 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 178
TABLE 129 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 179
TABLE 130 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2019 (USD MILLION) 179
TABLE 131 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020–2025 (USD MILLION) 180
TABLE 132 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 180
TABLE 133 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 181
TABLE 134 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2019 (USD MILLION) 181
TABLE 135 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 181
TABLE 136 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2019 (USD MILLION) 182
TABLE 137 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 182
TABLE 138 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2019 (USD MILLION) 182
TABLE 139 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 183
12.3.5 SPAIN 183
12.3.5.1 Spain’s growing chemical industry is a major factor supporting the in vitro toxicology testing market in the country 183
TABLE 140 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 184
TABLE 141 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 184
TABLE 142 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2019 (USD MILLION) 184
TABLE 143 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020–2025 (USD MILLION) 185
TABLE 144 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 185
TABLE 145 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 186
TABLE 146 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2019 (USD MILLION) 186
TABLE 147 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 186
TABLE 148 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2019 (USD MILLION) 187
TABLE 149 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 187
TABLE 150 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2019 (USD MILLION) 187
TABLE 151 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 188

12.3.6 REST OF EUROPE 188
TABLE 152 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 189
TABLE 153 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 189
TABLE 154 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION) 190
TABLE 155 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION) 190
TABLE 156 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 191
TABLE 157 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 191
TABLE 158 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION) 192
TABLE 159 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 192
TABLE 160 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION) 192
TABLE 161 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION) 193
TABLE 162 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION) 193
TABLE 163 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION) 193
12.4 NORTH AMERICA 194
FIGURE 28 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA, 2017 194
FIGURE 29 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT 195
TABLE 164 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 196
TABLE 165 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020–2025 (USD MILLION) 196
TABLE 166 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 196
TABLE 167 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 197
TABLE 168 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION) 197
TABLE 169 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION) 198
TABLE 170 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 198
TABLE 171 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 199
TABLE 172 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION) 199
TABLE 173 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 200
TABLE 174 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION) 200
TABLE 175 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION) 200
TABLE 176 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION) 201
TABLE 177 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION) 201
12.4.1 US 201
12.4.1.1 The US dominates the North American in vitro toxicology testing market due to a growing focus on biomarker discovery and research in the field of structure-based drug design 201
TABLE 178 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 202
TABLE 179 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 203
TABLE 180 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2019 (USD MILLION) 203
TABLE 181 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020–2025 (USD MILLION) 204
TABLE 182 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 204
TABLE 183 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 205
TABLE 184 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2019 (USD MILLION) 205
TABLE 185 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 205
TABLE 186 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2019 (USD MILLION) 206
TABLE 187 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 206
TABLE 188 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2019 (USD MILLION) 206
TABLE 189 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 207
12.4.2 CANADA 207
12.4.2.1 Strong support for R&D and focus on developing new therapies will support market growth in Canada 207
TABLE 190 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 208
TABLE 191 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 208
TABLE 192 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2019 (USD MILLION) 209
TABLE 193 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020–2025 (USD MILLION) 209
TABLE 194 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 210
TABLE 195 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 210
TABLE 196 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2019 (USD MILLION) 211
TABLE 197 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 211
TABLE 198 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2019 (USD MILLION) 211
TABLE 199 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 212
TABLE 200 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2019 (USD MILLION) 212
TABLE 201 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 212
12.5 ASIA PACIFIC 213
FIGURE 30 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT 214
TABLE 202 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 215
TABLE 203 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2020–2025 (USD MILLION) 215
TABLE 204 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 215
TABLE 205 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 216
TABLE 206 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION) 216
TABLE 207 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION) 217
TABLE 208 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 217
TABLE 209 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 218
TABLE 210 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION) 218
TABLE 211 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 219
TABLE 212 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2019 (USD MILLION) 219
TABLE 213 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 219
TABLE 214 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2019 (USD MILLION) 220
TABLE 215 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 220
12.5.1 CHINA 220
12.5.1.1 Increasing international pressure to ban animal testing methods will propel market growth in the coming years 220
TABLE 216 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 221
TABLE 217 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 222
TABLE 218 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2019 (USD MILLION) 222
TABLE 219 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020–2025 (USD MILLION) 223
TABLE 220 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 223
TABLE 221 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 224
TABLE 222 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2019 (USD MILLION) 224
TABLE 223 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 225
TABLE 224 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION) 225
TABLE 225 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 225
TABLE 226 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2019 (USD MILLION) 226
TABLE 227 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 226
12.5.2 JAPAN 226
12.5.2.1 Use of artificial skin patches and plates of cultured human cells has increased in Japan 226
TABLE 228 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 227
TABLE 229 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 228
TABLE 230 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2019 (USD MILLION) 228
TABLE 231 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020–2025 (USD MILLION) 229
TABLE 232 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 229
TABLE 233 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 230
TABLE 234 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2019 (USD MILLION) 230
TABLE 235 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 231
TABLE 236 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION) 231
TABLE 237 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 231
TABLE 238 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION) 232
TABLE 239 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 232
12.5.3 INDIA 232
12.5.3.1 Growing CRAMs industry and the ban on the use of animals in cosmetics and universities are likely to propel market growth 232
TABLE 240 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 233
TABLE 241 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 234
TABLE 242 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2019 (USD MILLION) 234
TABLE 243 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020–2025 (USD MILLION) 235
TABLE 244 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 235
TABLE 245 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 236
TABLE 246 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2019 (USD MILLION) 236
TABLE 247 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020–2025 (USD MILLION) 237
TABLE 248 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2019 (USD MILLION) 237
TABLE 249 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020–2025 (USD MILLION) 237
TABLE 250 INDIA: IN VITRO TRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2019 (USD MILLION) 238
TABLE 251 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020–2025 (USD MILLION) 238
12.5.4 REST OF ASIA PACIFIC 238
TABLE 252 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 240
TABLE 253 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 240
TABLE 254 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET,
BY TYPE, 2017–2019 (USD MILLION) 241
TABLE 255 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET,
BY TYPE, 2020–2025 (USD MILLION) 241
TABLE 256 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 242
TABLE 257 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 242
TABLE 258 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET,
BY TECHNOLOGY, 2017–2019 (USD MILLION) 243
TABLE 259 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET,
BY TECHNOLOGY, 2020–2025 (USD MILLION) 243
TABLE 260 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET,
BY INDUSTRY, 2017–2019 (USD MILLION) 243
TABLE 261 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET,
BY INDUSTRY, 2020–2025 (USD MILLION) 244
TABLE 262 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION) 244
TABLE 263 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION) 244
12.6 LATIN AMERICA 245
12.6.1 LOW COST OF DRUG TRIALS HAVE MADE LATIN AMERICA A POPULAR OUTSOURCING MARKET 245
TABLE 264 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 246
TABLE 265 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 246
TABLE 266 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2019 (USD MILLION) 247
TABLE 267 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020–2025 (USD MILLION) 247
TABLE 268 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 248
TABLE 269 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 248
TABLE 270 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2019 (USD MILLION) 249
TABLE 271 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION) 249
TABLE 272 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2019 (USD MILLION) 249
TABLE 273 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020–2025 (USD MILLION) 250
TABLE 274 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2019 (USD MILLION) 250
TABLE 275 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020–2025 (USD MILLION) 250
12.7 MIDDLE EAST & AFRICA 251
12.7.1 INCREASING R&D INVESTMENTS AND FOCUS ON THE DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH 251
TABLE 276 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY PRODUCT & SERVICE, 2017–2019 (USD MILLION) 252
TABLE 277 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 252
TABLE 278 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET,
BY TYPE, 2017–2019 (USD MILLION) 252
TABLE 279 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET,
BY TYPE, 2020–2025 (USD MILLION) 253
TABLE 280 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY TOXICITY ENDPOINT & TEST, 2017–2019 (USD MILLION) 253
TABLE 281 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY TOXICITY ENDPOINT & TEST, 2020–2025 (USD MILLION) 254
TABLE 282 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY TECHNOLOGY, 2017–2019 (USD MILLION) 254
TABLE 283 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY TECHNOLOGY, 2020–2025 (USD MILLION) 255
TABLE 284 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY INDUSTRY, 2017–2019 (USD MILLION) 255
TABLE 285 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY INDUSTRY, 2020–2025 (USD MILLION) 255
TABLE 286 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY METHOD, 2017–2019 (USD MILLION) 256
TABLE 287 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY METHOD, 2020–2025 (USD MILLION) 256
13 COMPETITIVE LANDSCAPE 257
13.1 OVERVIEW 257
FIGURE 31 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2017 TO JUNE 2020 258
13.2 MARKET SHARE ANALYSIS 259
FIGURE 32 IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2018 259
13.3 COMPETITIVE LEADERSHIP MAPPING 260
13.3.1 VISIONARY LEADERS 261
13.3.2 INNOVATORS 261
13.3.3 DYNAMIC DIFFERENTIATORS 261
13.3.4 EMERGING COMPANIES 261
FIGURE 33 IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 262
13.4 COMPETITIVE SITUATION AND TRENDS 263
13.4.1 PRODUCT & SERVICE LAUNCHES 263
TABLE 288 PRODUCT & SERVICE LAUNCHES, 2017–2020 263
13.4.2 EXPANSIONS 264
TABLE 289 EXPANSIONS, 2017–2020 264
13.4.3 ACQUISITIONS 264
TABLE 290 ACQUISITIONS, 2017–2020 265
13.4.4 OTHER STRATEGIES 266
TABLE 291 OTHER STRATEGIES, 2017–2020 266

14 COMPANY PROFILES 267
(Business Overview, Products Offered, Recent Developments, MnM View)*
14.1 THERMO FISHER SCIENTIFIC, INC. 267
FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019) 267
14.2 MERCK KGAA 273
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2019) 273
14.3 EUROFINS SCIENTIFIC SE 278
FIGURE 36 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2019) 278
14.4 GE HEALTHCARE 286
FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2019) 286
14.5 COVANCE, INC. 289
FIGURE 38 LABORATORY CORPORATION OF AMERICA HOLDINGS:
COMPANY SNAPSHOT (2019) 289
14.6 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 293
FIGURE 39 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.:
COMPANY SNAPSHOT (2019) 293
14.7 SGS S.A. 297
FIGURE 40 SGS S.A.: COMPANY SNAPSHOT (2019) 297
14.8 BIO-RAD LABORATORIES, INC. 302
FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019) 302
14.9 QIAGEN N.V. 305
FIGURE 42 QIAGEN N.V.: COMPANY SNAPSHOT (2019) 305
14.10 CYPROTEX PLC 308
FIGURE 43 EVOTEC AG: COMPANY SNAPSHOT (2019) 308
14.11 PROMEGA CORPORATION 314
14.12 CATALENT, INC. 317
FIGURE 44 CATALENT, INC.: COMPANY SNAPSHOT (2019) 317
14.13 GENTRONIX LIMITED 319
14.14 MB RESEARCH LABORATORIES 320
14.15 BIOIVT 322
14.16 CREATIVE BIOLABS 325
14.17 GVK BIOSCIENCES PRIVATE LIMITED 326
14.18 SHANGHAI MEDICILON INC. 327
14.19 CREATIVE BIOARRAY 328
14.20 INSPHERO 329
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15 RELATED MARKETS 330
15.1 INTRODUCTION 330
15.2 IN VIVO TOXICOLOGY MARKET 330
15.2.1 MARKET DEFINITION 330
15.2.2 LIMITATIONS 330
15.2.3 MARKET OVERVIEW 330
FIGURE 45 CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE IN VIVO TOXICOLOGY MARKET DURING THE FORECAST PERIOD 331
15.3 IN VIVO TOXICOLOGY MARKET, BY PRODUCT 331
15.3.1 CONSUMABLES 331
TABLE 292 IN VIVO TOXICOLOGY CONSUMABLES MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 332
15.3.2 INSTRUMENTS 332
TABLE 293 IN VIVO TOXICOLOGY INSTRUMENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION) 333
15.4 IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT 333
15.4.1 IMMUNOTOXICITY 333
TABLE 294 IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 334
15.4.2 SYSTEMIC TOXICITY 335
TABLE 295 IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 335
15.4.3 CARCINOGENICITY 336
TABLE 296 IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 336
15.4.4 GENOTOXICITY 337
TABLE 297 IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 338
15.4.5 DEVELOPMENTAL AND REPRODUCTIVE TOXICITY (DART) 338
TABLE 298 IN VIVO TOXICOLOGY MARKET FOR DEVELOPMENTAL AND REPRODUCTIVE TOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 339
15.4.6 OTHER TOXICOLOGY ENDPOINTS 339
TABLE 299 IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 340
15.5 IN VIVO TOXICOLOGY MARKET, BY REGION 340
15.5.1 NORTH AMERICA 340
TABLE 300 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2015–2022 (USD MILLION) 341
15.5.2 EUROPE 341
TABLE 301 EUROPE: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT,
2015–2022 (USD MILLION) 341
15.5.3 ASIA PACIFIC 342
TABLE 302 APAC: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT,
2015–2022 (USD MILLION) 342
15.5.4 LATIN AMERICA 342
TABLE 303 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2015–2022 (USD MILLION) 342
15.5.5 MIDDLE EAST & AFRICA 343
TABLE 304 MIDDLE EAST & AFRICA: IN VIVO TOXICOLOGY MARKET, BY TOXICITY ENDPOINT, 2015–2022 (USD MILLION) 343
16 APPENDIX 344
16.1 INSIGHTS OF INDUSTRY EXPERTS 344
16.2 DISCUSSION GUIDE 345
16.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 351
16.4 AVAILABLE CUSTOMIZATIONS 353
16.5 RELATED REPORTS 353
16.6 AUTHOR DETAILS 354

★調査レポート[体外毒性検査の世界市場予測(〜2025):製品別(アッセイ(ウエスタンブロット、組織培養)、機器、アッセイ試薬、ソフトウェア)、毒性エンドポイント別(ADME、皮膚刺激性、腐食)、産業別(医薬品、化粧品)、新型コロナウイルスの影響] ( In Vitro Toxicity Testing Market by Product (Assay (Western Blot, Tissue Culture),Equipment, Assay Reagent, Software), Toxicity Endpoints (ADME, Skin Irritation, Corrosion),Industry (Pharmaceutical, Cosmetics)-COVID-19 Impact - Global Forecast to 2025 / BT 2373) 販売に関する免責事項
[体外毒性検査の世界市場予測(〜2025):製品別(アッセイ(ウエスタンブロット、組織培養)、機器、アッセイ試薬、ソフトウェア)、毒性エンドポイント別(ADME、皮膚刺激性、腐食)、産業別(医薬品、化粧品)、新型コロナウイルスの影響] ( In Vitro Toxicity Testing Market by Product (Assay (Western Blot, Tissue Culture),Equipment, Assay Reagent, Software), Toxicity Endpoints (ADME, Skin Irritation, Corrosion),Industry (Pharmaceutical, Cosmetics)-COVID-19 Impact - Global Forecast to 2025 / BT 2373) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆